Synthesis and control of process-related impurities in the β-lactamase inhibitor drug substance zidebactam

被引：1

作者：

Pund, Amit A. ^{[1
]}

Rane, Vipul P. ^{[1
]}

Raut, Vivek T. ^{[1
]}

Ahirrao, Vinod K. ^{[1
]}

Yeole, Ravindra D. ^{[1
]}

Joshi, Sanjeev ^{[1
]}

Bhavsar, Satish ^{[1
]}

Rafeeq, Mohammad ^{[1
]}

Yadav, Ramprasad ^{[1
]}

Merwade, Arvind Y. ^{[1
]}

机构：

[1] Wockhardt Res Ctr, MIDC, Chikalthana, D-4, Aurangabad, India

来源：

SYNTHETIC COMMUNICATIONS | 2023年 / 53卷 / 13期

关键词：

beta-lactamase inhibitor; impurities; stereoisomer; zidebactam;

D O I：

10.1080/00397911.2023.2209677

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Zidebactam is a novel extended spectrum beta-lactamase inhibitor (ESBLI). It's combination with cefepime (WCK 5222) is in phase III clinical studies. Five process impurities were found in zidebactam (1) drug substance using process development through reverse phase high performance liquid chromatography (HPLC) method. To give access to the reference standards for the impurity profile of the drug substance as well as the final product, these process impurities of compound 1, have been synthesized and characterized. [GRAPHICS] .

引用

页码：1041 / 1052

页数：12

共 50 条

[31] Effect of Process-Related Impurities on the Electrophysical Parameters of a MOS Transistor
Odzhaev V.B.
Petlitskii A.N.
Prosolovich V.S.
Filipenya V.A.
Yavid V.Y.
Yankovskii Y.N.
Russian Microelectronics, 2021, 50 (01) : 63 - 68
[32] Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance
Karthikeyan, K.
Arularasu, G. T.
Murali, V.
Pillai, K. Chandrasekara
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 54 (01) : 208 - 212
[33] Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine
Dousa, Michal
Srbek, Jan
Radl, Stanislav
Cerny, Josef
Klecan, Ondrej
Havlicek, Jaroslav
Tkadlecova, Marcela
Pekarek, Tomas
Gibala, Petr
Novakova, Lucie
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 94 : 71 - 76
[34] A validated stability indicating HPLC method for the determination of process-related impurities in pantoprazole bulk drug and formulations
Pandey, Saurabh
Pandey, Preeti
Mishra, Durgesh
Singh, Umesh Kumar
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 49 (01) : 175 - 184
[35] Identification, characterization, and synthesis of process-related impurities in antiproliferative agent TQ-B3203
Zhang, Xiquan
Cao, Meng
Xing, Jing
Zheng, Ming
Liu, Fei
Dong, Ping
Tian, Xin
Xu, Hongjiang
Zhang, Laifang
Gu, Hongmei
Yang, Ling
Li, Rui
Ji, Min
Gu, Ning
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2016, 39 (10) : 488 - 496
[36] SEPARATION AND QUANTIFICATION OF PROCESS RELATED IMPURITIES AND DIASTEREOMERS IN APREPITANT BULK DRUG SUBSTANCE
Ashok, Sigala
Raghunadhababu, C. V.
Varma, M. Satish
Balaswamy, G.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2012, 35 (05) : 677 - 687
[37] Identification, Characterization, and Quantification of Impurities of Safinamide Mesilate: Process-Related Impurities and Degradation Products
Zou, Liang
Sun, Lili
Zhang, Hui
Hui, Wenkai
Zou, Qiaogen
Zhu, Zheying
JOURNAL OF AOAC INTERNATIONAL, 2017, 100 (04) : 1029 - 1037
[38] Isolation, Identification and Characterization of Process Related Impurities in Losartan Potassium Drug Substance
Thapa, M.
Nautiyal, R.
Datar, M.
Singh, A. K.
ASIAN JOURNAL OF CHEMISTRY, 2010, 22 (06) : 4295 - 4298
[39] Isolation, identification and characterization of two novel process-related impurities in olanzapine
Zhuang, Tao
Zhang, Wen
Cao, Longji
He, Kai
Wang, Yu
Li, Jing
Chen, Liang
Liu, Bifeng
Zhang, Guisen
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 152 : 188 - 196
[40] Monitoring process-related impurities in biologics–host cell protein analysis
Katrine Pilely
Martin Rask Johansen
Rikke Raaen Lund
Thomas Kofoed
Thomas Kjærsgaard Jørgensen
Lars Skriver
Ejvind Mørtz
Analytical and Bioanalytical Chemistry, 2022, 414 : 747 - 758

← 1 2 3 4 5 →